Oxford Eye Clinic & Optical, Pllc - Medicare Optometrist in Oxford, MS

Oxford Eye Clinic & Optical, Pllc is a medicare enrolled "Optometrist" provider in Oxford, Mississippi. Their current practice location is 2167 S Lamar Blvd, Oxford, Mississippi. You can reach out to their office (for appointments etc.) via phone at (662) 234-6683.

Oxford Eye Clinic & Optical, Pllc is licensed to practice in * (Not Available) (license number ) and it also participates in the medicare program. Oxford Eye Clinic & Optical, Pllc is enrolled with medicare and should accept medicare assignments and since they are enrolled in medicare, they may order Medicare Part D Prescription drugs, if eligible. The facility's NPI Number is 1154833572.

Contact Information

Oxford Eye Clinic & Optical, Pllc
2167 S Lamar Blvd,
Oxford, MS 38655-5223
(662) 234-6683
(662) 234-4413



Healthcare Provider's Profile

Full NameOxford Eye Clinic & Optical, Pllc
TypeFacility
SpecialityOptometrist
Location2167 S Lamar Blvd, Oxford, Mississippi
Accepts Medicare AssignmentsMedicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1154833572
  • Provider Enumeration Date: 10/25/2017
  • Last Update Date: 10/20/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 7416214010
  • Enrollment ID: O20171207001067

Medical Identifiers

Medical identifiers for Oxford Eye Clinic & Optical, Pllc such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1154833572NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
152W00000XOptometrist (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Oxford Eye Clinic & Optical, Pllc acts as a billing entity for following providers:
Provider NameWilliam Murray Edouard Strickland
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1093704223
PECOS PAC ID: 0446322135
Enrollment ID: I20080714000199

News Archive

AMAG Pharmaceuticals' abstract on ferumoxytol for CKD accepted for presentation at NKF 2010

AMAG Pharmaceuticals, Inc. today announced that one abstract has been accepted for presentation at the National Kidney Foundation 2010 Spring Clinical Meeting being held April 13-17, 2010 in Orlando, FL.

RXi Pharmaceuticals to present data on rxRNA therapeutic platform development at upcoming conferences

RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that senior members of its management will be presenting at upcoming conferences and will highlight critical aspects of the development of RXi's next generation rxRNA™ therapeutic platform as well as specific preclinical data generated with this platform.

Vitamin D supplementation does not appear to prevent bone loss in postmenopausal black women

Although there is general agreement on the optimal calcium intake recommended for reducing postmenopausal bone loss, and it is recognized that vitamin D is important in calcium maintenance, the optimal intake of vitamin D is controversial, according to background information in the article.

Many patients with diabetes say burden of care rivals complications of disease

Many patients with diabetes say that the inconvenience and discomfort of constant therapeutic vigilance, particularly multiple daily insulin injections, has as much impact on their quality of life as the burden of intermediate complications, researchers from the University of Chicago report in the October 2007 issue of Diabetes Care.

Read more Medical News

› Verified 7 days ago

Provider NameRyan S Wally
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1851555106
PECOS PAC ID: 4789744426
Enrollment ID: I20081125000438

News Archive

AMAG Pharmaceuticals' abstract on ferumoxytol for CKD accepted for presentation at NKF 2010

AMAG Pharmaceuticals, Inc. today announced that one abstract has been accepted for presentation at the National Kidney Foundation 2010 Spring Clinical Meeting being held April 13-17, 2010 in Orlando, FL.

RXi Pharmaceuticals to present data on rxRNA therapeutic platform development at upcoming conferences

RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that senior members of its management will be presenting at upcoming conferences and will highlight critical aspects of the development of RXi's next generation rxRNA™ therapeutic platform as well as specific preclinical data generated with this platform.

Vitamin D supplementation does not appear to prevent bone loss in postmenopausal black women

Although there is general agreement on the optimal calcium intake recommended for reducing postmenopausal bone loss, and it is recognized that vitamin D is important in calcium maintenance, the optimal intake of vitamin D is controversial, according to background information in the article.

Many patients with diabetes say burden of care rivals complications of disease

Many patients with diabetes say that the inconvenience and discomfort of constant therapeutic vigilance, particularly multiple daily insulin injections, has as much impact on their quality of life as the burden of intermediate complications, researchers from the University of Chicago report in the October 2007 issue of Diabetes Care.

Read more Medical News

› Verified 7 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Oxford Eye Clinic & Optical, Pllc is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Oxford Eye Clinic & Optical, Pllc
2167 S Lamar Blvd,
Oxford, MS 38655-5223

Ph: (662) 234-6683
Oxford Eye Clinic & Optical, Pllc
2167 S Lamar Blvd,
Oxford, MS 38655-5223

Ph: (662) 234-6683

News Archive

AMAG Pharmaceuticals' abstract on ferumoxytol for CKD accepted for presentation at NKF 2010

AMAG Pharmaceuticals, Inc. today announced that one abstract has been accepted for presentation at the National Kidney Foundation 2010 Spring Clinical Meeting being held April 13-17, 2010 in Orlando, FL.

RXi Pharmaceuticals to present data on rxRNA therapeutic platform development at upcoming conferences

RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that senior members of its management will be presenting at upcoming conferences and will highlight critical aspects of the development of RXi's next generation rxRNA™ therapeutic platform as well as specific preclinical data generated with this platform.

Vitamin D supplementation does not appear to prevent bone loss in postmenopausal black women

Although there is general agreement on the optimal calcium intake recommended for reducing postmenopausal bone loss, and it is recognized that vitamin D is important in calcium maintenance, the optimal intake of vitamin D is controversial, according to background information in the article.

Many patients with diabetes say burden of care rivals complications of disease

Many patients with diabetes say that the inconvenience and discomfort of constant therapeutic vigilance, particularly multiple daily insulin injections, has as much impact on their quality of life as the burden of intermediate complications, researchers from the University of Chicago report in the October 2007 issue of Diabetes Care.

Read more News

› Verified 7 days ago


Optometrist in Oxford, MS

Michael G Turner, O.D.
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 1110 N Lamar Blvd, Oxford, MS 38655
Phone: 662-234-0400    Fax: 662-234-0403
Dr. Cindy Jeanne Williams, O.D.
Optometrist
Medicare: Medicare Enrolled
Practice Location: 309 Garner Street, Oxford, MS 38655
Phone: 678-357-3648    Fax: 770-938-2943
Dr. Katie E Stuckey, OD
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 1628 Highway 30 E, Oxford, MS 38655
Phone: 662-234-3937    Fax: 662-234-3898
Oxford Eye Clinic
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 2167 S Lamar Blvd, Oxford, MS 38655
Phone: 662-234-6683    Fax: 662-234-4413
Dr. William M. Strickland, O.D.
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 2167 S Lamar Blvd, Oxford, MS 38655
Phone: 662-234-6683    Fax: 662-234-4413
Dr. Eric Dale Randle, O. D.
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 2708 West Oxford Loop, Suite 110, Oxford, MS 38655
Phone: 662-380-5041    Fax: 662-380-5042

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.